From Nasdaq:



This article discusses the concept of growth at a reasonable price (GARP) stocks, which represent a middle ground between high-valued growth stocks and very conservative value stocks. GARP stocks have lower valuations and strong balance sheets, making them less likely to experience significant declines or bankruptcy. The article highlights three top GARP stock options for long-term investors: GSK, Micron Technology, and Wendy’s.

GSK has seen advancements in its RSV vaccine and anti-cancer drug, with promising sales forecasts and successful trials. Micron Technology reported strong financial performance and positive outlook, with its business fundamentals expected to rebound. Wendy’s experienced growth in its top line and operating profit, with strong expansion overseas.

The forward price-earnings ratio for GSK, Micron Technology, and Wendy’s is described as attractive, making these GARP stocks viable options for balanced growth. Overall, the article suggests that these GARP stocks offer strong growth potential with relatively low risk, making them appealing choices for long-term investors.



Original: 3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth